News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,208 Results
Type
Article (5099)
Company Profile (24)
Press Release (227085)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82292)
Career Advice (464)
Deals (15062)
Drug Delivery (8)
Drug Development (19114)
Employer Resources (30)
FDA (3687)
Job Trends (3919)
News (120267)
Policy (7517)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (294)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14818)
ALS (38)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (40)
Approvals (3788)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2876)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (889)
Cardiovascular disease (61)
Career advice (396)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (167)
Cervical cancer (5)
Clinical research (16719)
Collaboration (353)
Compensation (371)
Complete response letters (8)
COVID-19 (316)
CRISPR (13)
C-suite (338)
Cystic fibrosis (28)
Data (1328)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2115)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42761)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39184)
Executive appointments (426)
FDA (4426)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (340)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (423)
Guidances (197)
Healthcare (5049)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (342)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7885)
IRA (3)
Job creations (1122)
Job search strategy (362)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (107)
Leadership (5)
Legal (2337)
Liver cancer (21)
Longevity (2)
Lung cancer (95)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (50)
Medical device (3919)
Medtech (3929)
Mergers & acquisitions (7583)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (539)
NextGen: Class of 2026 (1674)
Non-profit (730)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25229)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5003)
Phase 2 (7241)
Phase 3 (5808)
Pipeline (1963)
Policy (17)
Postmarket research (625)
Preclinical (1948)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (110)
Rare diseases (179)
Real estate (1887)
Recruiting (8)
Regulatory (5540)
Reports (17)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Last 7 days (146)
Last 30 days (563)
Last 365 days (8887)
2026 (784)
2025 (9041)
2024 (11049)
2023 (13215)
2022 (18689)
2021 (19726)
2020 (18282)
2019 (13227)
2018 (10210)
2017 (10002)
2016 (9157)
2015 (12120)
2014 (9589)
2013 (7707)
2012 (8331)
2011 (8796)
2010 (8634)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11792)
Australia (1690)
California (3544)
Canada (1138)
China (167)
Colorado (143)
Connecticut (162)
Delaware (73)
Europe (25492)
Florida (542)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (355)
Massachusetts (2803)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1018)
New Mexico (5)
New York (815)
North Carolina (479)
North Dakota (4)
Northern California (1856)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1304)
Tennessee (61)
Texas (480)
United States (12339)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,208 Results for "emmes corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma
January 16, 2025
·
3 min read
Emmes Acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation
October 5, 2023
·
3 min read
Business
Navigating Funding Freezes and AI Frontiers
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis discusses key themes from BIO and DIA, including the funding environment, with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter Ronco, CEO of Emmes Corporation, and Phil Vanek, founder of Redline Bio Advisors.
June 20, 2025
·
1 min read
·
Lori Ellis
Business
Emmes Appoints Peter Ronco as Chief Executive Officer
Emmes today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.
September 20, 2023
·
3 min read
Drug Development
ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
ILiAD Biotechnologies, LLC today announced the selection of Emmes Group, a global contract research and technology organization, to conduct upcoming Phase III studies of its lead pertussis vaccine candidate, BPZE1. ILiAD and Emmes Group are currently working to finalize the definitive agreement.
June 24, 2024
·
4 min read
BioCapital
Matt Bond Has Joined Emmes as Chief Financial Officer
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Matt Bond has become its chief financial officer.
October 3, 2023
·
2 min read
Business
Emmes Acquires Essex Management
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the acquisition of Essex Management.
March 21, 2023
·
3 min read
Press Releases
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
September 4, 2024
·
2 min read
Business
Kristin Judge Joins Emmes as Chief Growth Officer
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Kristin Judge has joined as its chief growth officer, a newly created executive leadership position.
May 25, 2023
·
3 min read
BioCapital
Emmes Launches Cell and Gene Therapy Center
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
December 8, 2022
·
3 min read
1 of 23,221
Next
